FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1640550834> ?p ?o ?g. }

• W1640550834 endingPage "498" @default.
• W1640550834 startingPage "488" @default.
• W1640550834 abstract "The aim of the study was to assess the incidence and costs of adverse events (AEs) among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors (NNRTIs) from the health care system perspective.US medical and pharmacy claims during 2004-2009 were examined to select adult new NNRTI users with HIV infection. The incidence of selected AEs and time to occurrence were assessed during the first year. Episodes of care for each AE were identified using claims associated with AE management. For each AE, a propensity score model was used to match patients with an AE to those without (1:4) based on the propensity of having an AE. Mean total health care costs, AE-associated costs and incremental costs per episode, and annual total health care costs per patient were calculated.Of the 2548 NNRTI-treated patients, 29.3% experienced AEs. The incidence ranged from 0.4 episodes/1000 person-years for suicide/self-injury to 14.9 episodes/1000 person-years for dizziness, 49.8 episodes/1000 person-years for depression and 150.3 episodes/1000 person-years for lipid disorder. The mean AE-associated cost (duration) per episode ranged from $586 (88 days) for lipid disorder to $975 (33 days) for rash, $2760 (73 days) for sleep-related symptoms and $4434 (41 days) for nausea/vomiting. The mean incremental cost per episode ranged from $1580 for rash to $2032 for lipid disorder, $8307 for sleep-related symptoms and $12 833 for nausea/vomiting. During the 12 months following NNRTI initiation, the mean annual total health care cost was $27 299 (efavirenz: $26 185; other NNRTIs: $34 993) and AE-associated costs were $608 (efavirenz: $554; other NNRTIs: $979) among all NNRTI users.With treatment increasing patient survival, comparisons of therapeutic regimens should consider treatment-associated AEs. Findings from this study could be informative for clinicians and payers in managing HIV infection with NNRTIs." @default.
• W1640550834 created "2016-06-24" @default.
• W1640550834 creator A5006221714 @default.
• W1640550834 creator A5007305426 @default.
• W1640550834 creator A5030258917 @default.
• W1640550834 creator A5042690044 @default.
• W1640550834 creator A5048763748 @default.
• W1640550834 creator A5057985619 @default.
• W1640550834 creator A5062006247 @default.
• W1640550834 creator A5064948988 @default.
• W1640550834 creator A5074358267 @default.
• W1640550834 date "2014-03-18" @default.
• W1640550834 modified "2023-10-04" @default.
• W1640550834 title "Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors" @default.
• W1640550834 cites W114538374 @default.
• W1640550834 cites W1965160986 @default.
• W1640550834 cites W1971979811 @default.
• W1640550834 cites W1976730142 @default.
• W1640550834 cites W1977142127 @default.
• W1640550834 cites W1979036222 @default.
• W1640550834 cites W1988062692 @default.
• W1640550834 cites W1989281509 @default.
• W1640550834 cites W1998660799 @default.
• W1640550834 cites W2003077790 @default.
• W1640550834 cites W2008258552 @default.
• W1640550834 cites W2011593962 @default.
• W1640550834 cites W2015294909 @default.
• W1640550834 cites W2052332986 @default.
• W1640550834 cites W2058643347 @default.
• W1640550834 cites W2062389395 @default.
• W1640550834 cites W2066059923 @default.
• W1640550834 cites W2071059013 @default.
• W1640550834 cites W2076675434 @default.
• W1640550834 cites W2090669065 @default.
• W1640550834 cites W2110937893 @default.
• W1640550834 cites W2123101436 @default.
• W1640550834 cites W2127920422 @default.
• W1640550834 cites W2131850093 @default.
• W1640550834 cites W2137262613 @default.
• W1640550834 cites W2147662860 @default.
• W1640550834 cites W2150291618 @default.
• W1640550834 cites W2160230582 @default.
• W1640550834 cites W2162481460 @default.
• W1640550834 cites W2169910726 @default.
• W1640550834 cites W2318289184 @default.
• W1640550834 cites W52199297 @default.
• W1640550834 doi "https://doi.org/10.1111/hiv.12145" @default.
• W1640550834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24641448" @default.
• W1640550834 hasPublicationYear "2014" @default.
• W1640550834 type Work @default.
• W1640550834 sameAs 1640550834 @default.
• W1640550834 citedByCount "8" @default.
• W1640550834 countsByYear W16405508342015 @default.
• W1640550834 countsByYear W16405508342018 @default.
• W1640550834 countsByYear W16405508342021 @default.
• W1640550834 countsByYear W16405508342022 @default.
• W1640550834 crossrefType "journal-article" @default.
• W1640550834 hasAuthorship W1640550834A5006221714 @default.
• W1640550834 hasAuthorship W1640550834A5007305426 @default.
• W1640550834 hasAuthorship W1640550834A5030258917 @default.
• W1640550834 hasAuthorship W1640550834A5042690044 @default.
• W1640550834 hasAuthorship W1640550834A5048763748 @default.
• W1640550834 hasAuthorship W1640550834A5057985619 @default.
• W1640550834 hasAuthorship W1640550834A5062006247 @default.
• W1640550834 hasAuthorship W1640550834A5064948988 @default.
• W1640550834 hasAuthorship W1640550834A5074358267 @default.
• W1640550834 hasBestOaLocation W16405508341 @default.
• W1640550834 hasConcept C104863432 @default.
• W1640550834 hasConcept C120665830 @default.
• W1640550834 hasConcept C121332964 @default.
• W1640550834 hasConcept C126322002 @default.
• W1640550834 hasConcept C197934379 @default.
• W1640550834 hasConcept C2778570526 @default.
• W1640550834 hasConcept C2780580376 @default.
• W1640550834 hasConcept C2780852908 @default.
• W1640550834 hasConcept C512399662 @default.
• W1640550834 hasConcept C61511704 @default.
• W1640550834 hasConcept C71924100 @default.
• W1640550834 hasConceptScore W1640550834C104863432 @default.
• W1640550834 hasConceptScore W1640550834C120665830 @default.
• W1640550834 hasConceptScore W1640550834C121332964 @default.
• W1640550834 hasConceptScore W1640550834C126322002 @default.
• W1640550834 hasConceptScore W1640550834C197934379 @default.
• W1640550834 hasConceptScore W1640550834C2778570526 @default.
• W1640550834 hasConceptScore W1640550834C2780580376 @default.
• W1640550834 hasConceptScore W1640550834C2780852908 @default.
• W1640550834 hasConceptScore W1640550834C512399662 @default.
• W1640550834 hasConceptScore W1640550834C61511704 @default.
• W1640550834 hasConceptScore W1640550834C71924100 @default.
• W1640550834 hasFunder F4320307765 @default.
• W1640550834 hasIssue "8" @default.
• W1640550834 hasLocation W16405508341 @default.
• W1640550834 hasLocation W16405508342 @default.
• W1640550834 hasOpenAccess W1640550834 @default.
• W1640550834 hasPrimaryLocation W16405508341 @default.
• W1640550834 hasRelatedWork W2005921017 @default.
• W1640550834 hasRelatedWork W2015534125 @default.
• W1640550834 hasRelatedWork W2040233681 @default.

• next